Global biomarker diagnostic testing market projected to reach $53.34 billion by 2021 from $27.95 billion in 2016 Zenosense’s device development incorporates key technology which is patent protected Technology platform could be used to test for a wide variety of common medical conditions that typically are undertaken in laboratory setting at huge expense Point of Care […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.